Course contents

Challenges to Develop Oral Pediatric Medicine for Neonates and Infants

Prescribers
Pharmacists

Pediatrics, Dosage forms

This course explores the challenges in developing oral pediatric medicines for neonates and infants, from clinical, biopharmaceutical, and formulation science perspectives. It begins with an introduction on the importance of formulation development in pediatric clinical practice. The course then covers clinical and biopharmaceutical considerations, focusing on how drug properties, absorption, and patient-specific factors influence therapeutic outcomes in this vulnerable population. This is followed by formulation development, outlining the steps involved in creating safe and effective oral medications and how to address common challenges. A section on excipients selection highlights the importance of choosing appropriate ingredients to ensure drug efficacy and patient safety.

The course concludes with a presentation on compounded medication by Dr. Hudson Polonini, who shares his expertise in personalized medicine and compounding standards for pediatric treatments.
 English (original audio)
  Prescribers, Pharmacists
Write your awesome label here.

Why should I take this course?

  • Understand the unique clinical and biopharmaceutical challenges in developing oral medications for neonates and infants.
  • Recognize the impact of drug properties and patient-specific factors on therapeutic outcomes in pediatric populations.
  • Learn the key steps involved in the formulation development of oral pediatric medicines.
  • Identify safe and appropriate excipients to ensure efficacy, stability, and patient safety.
  • Explore the role of compounding in personalized pediatric treatments and current standards in practice.

Course Lessons

Meet your instructors

Dr. Carolina C. V. Silva

Carolina is a pediatrician with clinical experience in medical treatment for children and newborn infants. She holds a master’s degree in health sciences from the Netherlands Institute of Health Sciences (NIHES) and a Ph.D. from the Erasmus Medical Center, focused on the early determinants of cardiovascular and brain health. Her expertise includes medical writing, medical translation, clinical research, and the development of innovative personalized treatments. Dr. Silva is the author of various articles involving medicine and compounding pharmaceutical fields.
Meet your instructor

Dr. Hudson Polonini

Hudson Polonini is a pharmacist with extensive experience as an educator as well as in the compounding market. His fields of expertise include quality control, quality assurance, and the development of innovative personalized pharmaceuticals and cosmetics. Dr. Polonini is author of numerous books and articles in the compounding pharmaceutical field and its therapeutic applications.